Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Paladin to market Watson's Oxytrol in Canada

Jan. 12, 2004

COMBAT study to assess dutasteride plus tamsulosin for BPH

Dec. 18, 2003

New PDE5 inhibitors reported by SK Chemicals and In2Gen team

Dec. 18, 2003

Bayer acquires Fosrenol rights in Japan

Dec. 12, 2003

Roche claims novel alpha1A-adrenoceptor agonists for urinary incontinence and other uses

Dec. 3, 2003

Enrollment completed in phase IIa BPH study of BXL-628

Dec. 2, 2003

New tachykinin NK1 antagonists and their use claimed by Kyorin team

Dec. 1, 2003

Improved penile erection in rats treated with ABT-724

Dec. 1, 2003

European CPMP issues positive opinion for oxybutynin transdermal patch

Nov. 26, 2003

New muscarinic M3 antagonists and their use in urinary incontinence, COPD, IBS, etc.

Nov. 25, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...